OBJECTIVES: Osteoporosis is a chronic disease characterized by low bone density and an increased risk of fractures. It is a major public health concern in the United States, affecting over 10 million individuals and causing significant morbidity, mortality, and healthcare costs. The aim of this study is to estimate the total cost and expenditure of osteoporosis in the United States using data from the Medical Expenditure Panel Survey (MEPS).

METHODS: The MEPS database was used to identify individuals aged 50 years and older with osteoporosis. The direct and indirect costs of osteoporosis were calculated using the health care expenditures, productivity losses, and informal care costs. Additionally, the cost distribution across demographic groups was examined.

RESULTS: The majority of osteoporosis cases were women (82.9%) and individuals aged 65 years and older (70.2%). The analysis revealed that the prescription medication expenses accounted for 57.5% of the total cost. The average annual cost per person with osteoporosis was $6,471. The average total cost of osteoporosis was highest among individuals aged 85 years and older compared to the other aged group.

CONCLUSIONS: Osteoporosis impose a significant economic burden on the United States healthcare system. The costs associated with prescription medications alone represent a significant financial strain. The results of this study suggest that preventive practices could help reduce the economic burden of osteoporosis, particularly among vulnerable populations.